PRECLINICAL DEVELOPMENT OF A NOVEL SMALL MOLECULE T CELL METABOLISM INHIBITOR TO PREVENT REJECTION AND ENABLE CALCINEURIN INHIBITOR-FREE ALLOGRAFT SU

The Johns Hopkins University

Investigators